This article may be unbalanced toward certain viewpoints. Please improve the article by adding information on neglected viewpoints, or discuss the issue on the talk page.(November 2021)
The principal purpose of the treatment was to improve Ashley's quality of life by limiting her growth in size, eliminating menstrual cramps and bleeding, and preventing discomfort from large breasts. The combination of the surgery and the estrogen therapy attracted much public comment and ethical analysis in early 2007, both supportive and condemning.[3][4]
Ashley's parents granted their first written interview to CNN Health in March 2008,[5]
and their second to The Guardian in March 2012.[6]
In addition, The Guardian published two interviews with mothers of a girl[7]
and a boy[8]
who had completed the treatment. A 2014 TV program and article tell the similar story of a girl in New Zealand.[9][10]
A survey on growth attenuation among pediatric endocrinologists was published in July 2015.[11][12]
^Cite error: The named reference blog was invoked but never defined (see the help page).
^Gunther, DF; Diekema, DS (2006). "Attenuating growth in children with profound developmental disability: a new approach to an old dilemma". Archives of Pediatrics & Adolescent Medicine. 160 (10): 1013–7. doi:10.1001/archpedi.160.10.1013. PMID17018459.